Back to Search
Start Over
[Erectile dysfunction in the hypertensive patient].
- Source :
-
Revue medicale suisse [Rev Med Suisse] 2024 Sep 11; Vol. 20 (886), pp. 1613-1616. - Publication Year :
- 2024
-
Abstract
- Hypertensive patients are frequently affected by erectile dysfunction (20-25%). This is often a manifestation of atherosclerosis, a systemic disease that itself requires management. Dietary measures and physical activity are beneficial for these patients. Regarding pharmacological options, these include modifying the antihypertensive treatment or using a phosphodiesterase type 5 inhibitor (PDE5 inhibitor) in males. The preferred antihypertensive treatments are angiotensin 2 receptor antagonists, ACE inhibitors, calcium channel blockers, and if necessary, a vasodilating beta-blocker (nébivolol). Thiazide and thiazide-like diuretics (with the exception of indapamide), traditional beta-blockers, and central antihypertensive agents should be avoided.<br />Competing Interests: Le Pr Ehret a des liens d’intérêts avec Servier et Novartis (mineur). Les autres auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
Details
- Language :
- French
- ISSN :
- 1660-9379
- Volume :
- 20
- Issue :
- 886
- Database :
- MEDLINE
- Journal :
- Revue medicale suisse
- Publication Type :
- Academic Journal
- Accession number :
- 39262188
- Full Text :
- https://doi.org/10.53738/REVMED.2024.20.886.1613